Eyevance Pharmaceuticals - Crunchbase Company Profile & Funding

Q: How much funding has Eyevance Pharmaceuticals raised to date?

Eyevance Pharmaceuticals has raised obfuscated.

Overview

Eyevance Pharmaceuticals

Total Funding

obfuscation

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Eyevance Pharmaceuticals

CB Rank

153038

Eyevance is a provider of ophthalmic products and therapies intended to address unmet medical needs.

Acquired by

Santen Pharmaceutical

Founded

obfuscation

Private

Venture - Series Unknown

Fort Worth, Texas, United States

51-100

eyevance.com/

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Key People

Jodi Luchs: Co-Medical Director
Past Role: Insightful Solutions, Founder, CEO

Details

Legal Name

Eyevance Pharmaceuticals LLC.

Operating Status

Closed

Company Type

For Profit

Founders

Jason Werner, Jerry St. Peter

About the Company

Eyevance is a provider of ophthalmic products and therapies intended to address unmet medical needs. The company's products target areas such as the anterior segment, posterior segment and glaucoma ailments, providing patients with optimal vision and a better quality of life.

Phone Number

(817) 677-6120

Predictions & Insights

Growth Prediction

See this Growth Prediction

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Eyevance Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Eyevance Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Eyevance Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Eyevance Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Eyevance Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Eyevance Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Eyevance Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Eyevance Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Eyevance Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Eyevance Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown